AVANOS MED INC's ticker is AVNS and the CUSIP is 05350V106. A total of 264 filers reported holding AVANOS MED INC in Q4 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $1,494 | +0.1% | 75 | 0.0% | 0.00% | – |
Q1 2024 | $1,493 | -11.2% | 75 | 0.0% | 0.00% | – |
Q4 2023 | $1,682 | +10.9% | 75 | 0.0% | 0.00% | – |
Q3 2023 | $1,517 | -20.9% | 75 | 0.0% | 0.00% | – |
Q2 2023 | $1,917 | -66.8% | 75 | -61.3% | 0.00% | – |
Q1 2023 | $5,770 | +29.2% | 194 | +17.6% | 0.00% | – |
Q4 2022 | $4,465 | +11.6% | 165 | 0.0% | 0.00% | – |
Q3 2022 | $4,000 | -20.0% | 165 | 0.0% | 0.00% | – |
Q2 2022 | $5,000 | -16.7% | 165 | 0.0% | 0.00% | – |
Q1 2022 | $6,000 | 0.0% | 165 | -2.4% | 0.00% | – |
Q4 2021 | $6,000 | +20.0% | 169 | 0.0% | 0.00% | – |
Q3 2021 | $5,000 | -16.7% | 169 | 0.0% | 0.00% | – |
Q2 2021 | $6,000 | -14.3% | 169 | 0.0% | 0.00% | – |
Q1 2021 | $7,000 | -12.5% | 169 | 0.0% | 0.00% | – |
Q4 2020 | $8,000 | -27.3% | 169 | -47.0% | 0.00% | -100.0% |
Q3 2020 | $11,000 | +22.2% | 319 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $9,000 | – | 319 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Paradice Investment Management LLC | 2,441,913 | $88,812,000 | 4.12% |
RGM Capital, LLC | 2,157,612 | $78,472,000 | 3.63% |
Millrace Asset Group, Inc. | 32,253 | $1,173,000 | 0.61% |
HEARTLAND ADVISORS INC | 240,724 | $8,755,000 | 0.51% |
Champlain Investment Partners, LLC | 2,607,033 | $94,818,000 | 0.45% |
Campbell & CO Investment Adviser LLC | 27,200 | $989,000 | 0.41% |
S.A. Mason LLC | 5,565 | $202,000 | 0.14% |
XTX Topco Ltd | 8,240 | $300,000 | 0.10% |
AIGEN INVESTMENT MANAGEMENT, LP | 15,186 | $552,000 | 0.10% |
OCCUDO QUANTITATIVE STRATEGIES LP | 16,875 | $614,000 | 0.09% |